SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001485003-22-000076
Filing Date
2022-06-17
Accepted
2022-06-17 08:01:15
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFA14A sesndefa14arssproposalremo.htm DEFA14A 17640
2 GRAPHIC sesnformremovalofrssprop001.jpg GRAPHIC 99773
3 sesnformremovalofrssprop002.jpg GRAPHIC 96584
4 sesnformremovalofrssprop003.jpg GRAPHIC 232047
5 sesnformremovalofrssprop004.jpg GRAPHIC 41015
  Complete submission text file 0001485003-22-000076.txt   665545
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36296 | Film No.: 221022416
SIC: 2834 Pharmaceutical Preparations